• <strike id="xmwty"><table id="xmwty"></table></strike>
    <progress id="xmwty"></progress>

      <b id="xmwty"></b>

      ×

      Global Expansion | Tonghua Dongbao's Mixed Isophane Protamine Human Insulin Injection (30R) Approved for Marketing in Uzbekistan

      Date:2025-03-23
      Author:東寶
      Views:2

      Tonghua Dongbao Pharmaceutical Co., Ltd. ("the Company") recently received marketing approval for its Mixed Isophane Protamine Human Insulin Injection (30R) from the regulatory authorities of Uzbekistan. This approval marks the Company's official entry into the Uzbek market for human insulin injections and is expected to further expand its overseas sales potential.

       

      Located in Central Asia, Uzbekistan is a key emerging market participating in the Belt and Road Initiative, with a large population and growing healthcare needs. As of October 2024, Uzbekistan had a total population of approximately 37.36 million. According to the 10th edition of the International Diabetes Federation (IDF) Global Diabetes Atlas (2021), there were about 1.3518 million diabetes patients aged 20 to 79 in Uzbekistan, with a prevalence rate of 6.3%. Among these, undiagnosed cases accounted for a high proportion, reaching 74%.

       

      To seize overseas opportunities, the Company has leveraged its competitive strengths and implemented a differentiated expansion strategy, tailored to the market size, growth potential, healthcare system, medication needs, and treatment habits of each target country or region. Its human insulin products are primarily positioned for emerging markets and developing countries in the Belt and Road Initiative, with customized sales strategies based on local conditions.

       

      As the Marketing Authorization Holder (MAH), the Company received the marketing license for Mixed Isophane Protamine Human Insulin Injection (30R) from the Ministry of Health of the Republic of Uzbekistan. This approval enriches the Company's international product portfolio, enhances its brand presence, expands its global business, and provides a replicable pathway for future overseas regulatory approvals. It is expected to accelerate the Company's expansion in emerging markets and Belt and Road countries and strengthen its competitiveness in the international market.


      0 国产在线看片av免费,91中文字幕 国产,国产丝袜脚足j在线视频播放,黄视频在线观看无码免费
    1. <strike id="xmwty"><table id="xmwty"></table></strike>
      <progress id="xmwty"></progress>

        <b id="xmwty"></b>

        国语免费一级毛片私人| 制服丝袜视频精品中文字幕| 91精品国产麻豆国产自产在线| 久久综合久久精品无码| 午夜福利亚洲国产精品| 欧美日韩在线视频一区| 国产精品女熟高潮视频| 日韩电影免费观看| 一区二区三区av无码观看| 国产亚洲欧美日韩高清| 亚洲欧洲日本无在线码不卡| 亚洲AV乱码一区二区三区按摩| 国产成年无码中国字幕av片| 亚洲国产精品VA在线看黑屌| 亚洲中文有码人妻在线| 欧美一区二区三区精品| 成人在线观看免费精品| 国产免费无码又爽又刺激高潮| 色欲AV无码国产永久播放| 亚洲最大的精品无码网站| 动漫无码无遮挡在线看中文| 污视频网站在线观看| 日躁夜躁狠狠躁2020| 一一本无码中文字幕| 日韩高清国产一区在线| 国产真实老熟女无套内射| 欧洲精品无码一区二区三区视频| 亚洲激情无码在线| 久久最新|